Detailed Information on Publication Record
2023
Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness
KVOKAČKOVÁ, Barbora, Radek FEDR, Daniela KUŽÍLKOVÁ, Jan STUCHLÝ, Adéla VÁVROVÁ et. al.Basic information
Original name
Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness
Authors
KVOKAČKOVÁ, Barbora (703 Slovakia, belonging to the institution), Radek FEDR, Daniela KUŽÍLKOVÁ, Jan STUCHLÝ, Adéla VÁVROVÁ, Jiří NAVRÁTIL, Pavel FABIAN, Róbert ONDRUŠŠEK, Petra OVESNÁ (203 Czech Republic, belonging to the institution), Ján REMŠÍK, Jan BOUCHAL, Tomáš KALINA and Karel SOUČEK (203 Czech Republic, guarantor, belonging to the institution)
Edition
Molecular Oncology, Wiley, 2023, 1574-7891
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 6.600 in 2022
RIV identification code
RIV/00216224:14310/23:00130413
Organization unit
Faculty of Science
UT WoS
000926769000001
Keywords in English
mass cytometry; phenotypic plasticity;single-cell profiles; triple-negative breastcancer; tumor heterogeneity; unsupervisedmachine learning algorithm
Tags
International impact, Reviewed
Změněno: 1/3/2024 12:57, Mgr. Marie Šípková, DiS.
Abstract
V originále
Triple-negative breast cancer (TNBC) is an aggressive and complex subtype of breast cancer that lacks targeted therapy. TNBC manifests characteristic, extensive intratumoral heterogeneity that promotes disease progression and influences drug response. Single-cell techniques in combination with next-generation computation provide an unprecedented opportunity to identify molecular events with therapeutic potential. Here, we describe the generation of a comprehensive mass cytometry panel for multiparametric detection of 23 phenotypic markers and 13 signaling molecules. This single-cell proteomic approach allowed us to explore the landscape of TNBC heterogeneity, with particular emphasis on the tumor microenvironment. We prospectively profiled freshly resected tumors from 26 TNBC patients. These tumors contained phenotypically distinct subpopulations of cancer and stromal cells that were associated with the patient's clinical status at the time of surgery. We further classified the epithelial-mesenchymal plasticity of tumor cells, and molecularly defined phenotypically diverse populations of tumor-associated stroma. Furthermore, in a retrospective tissue-microarray TNBC cohort, we showed that the level of CD97 at the time of surgery has prognostic potential.
Links
EF16_025/0007381, research and development project |
|